Glaukos Stock: The Second J-Code Rewrites The Risk Math (NYSE:GKOS)
- Glaukos: The Second J-Code Rewrites The Risk Math · seekingalpha.com · 2 days ago
We can't find the internet
Attempting to reconnectSomething went wrong!
Attempting to reconnectGlaukos’ iDose TR Phase 4 data shows greater IOP reduction with cataract surgery vs. surgery alone. Read more here.
Today reads warmer than 1 of the last 2 scored days. Click a bar to read that day's stories.